Your browser doesn't support javascript.
loading
High Throughput Sequencing for Clinical Tuberculosis: An Overview.
Ness, Tara E; DiNardo, Andrew; Farhat, Maha R.
Afiliação
  • Ness TE; Division of Pediatric Infectious Diseases, Baylor College of Medicine/Texas Children's Hospital, Houston, TX 77030, USA.
  • DiNardo A; Global TB Program, Baylor College of Medicine/Texas Childrens Hospital, Houston, TX 77030, USA.
  • Farhat MR; Global TB Program, Baylor College of Medicine/Texas Childrens Hospital, Houston, TX 77030, USA.
Pathogens ; 11(11)2022 Nov 14.
Article em En | MEDLINE | ID: mdl-36422596
High throughput sequencing (HTS) can identify the presence of Mycobacterium tuberculosis DNA in a clinical sample while also providing information on drug susceptibility. Multiple studies have provided a context for exploring the clinical application of HTS for TB diagnosis. The workflow challenges, strengths and limitations of the various sequencing platforms, and tools used for analysis are presented to provide a framework for further innovations in the field.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article